HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 355681Generated: October 29, 2026
Lawesson's reagent → 1,3-Dihydro-5-cyclohexyl-3(R,S)-[(benzyloxycarbonyl)-amino]-2H-1,4-benzodiazepin-2-thione
https://huagongshe.com/reaction/355681
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Lawesson's reagent | HCID 87949 | — |
| Reactant | Z-(R,S)-3-amino-5-cyclohexyl-2-oxo-1,4-benzodiazepine | HCID 135413400 | — |
| Solvent | Toluene | HCID 1140 | — |
| Product | 1,3-Dihydro-5-cyclohexyl-3(R,S)-[(benzyloxycarbonyl)-amino]-2H-1,4-benzodiazepin-2-thione | HCID 135753292 | — |
Reaction Steps
1,3-Dihydro-5-cyclohexyl-3(R,S)-[(benzyloxycarbonyl)-amino]-2H-1,4-benzodiazepin-2-one (M. Chambers, et. al. Biomed. Chem. Lett. 1993, in press) (1.09 g, 2.79 mmole) was mixed with 1.13 g (2.79 mmole) of 2,4-bis(4-methoxyphenyl)-1,3-dithia-2,4-diphosphetane-2,4-disulfide in 26 ml of toluene. The resulting suspension was heated to reflux for 1 hour. The reaction mixture was cooled, filtered, and concentrated in vacuo. The residue was flash chromatographed on silica gel (ethyl acetate-hexane, 1:3) and the product containing fractions were pooled and concentrated to give the title compound in approximately 85% purity. This material was recrystallized from hexane-ethyl acetate (1:1) to give 850 mg (75%) of the title compound in analytical form: m.p. 164°-165° C.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05834464 |
|---|
| Source dataset | uspto-grants-1998_11 |
|---|
| ORD ID | ord-b3b579e32430491d96e998cacb2eeb63 |
|---|
| Source note | uspto-grants-1998_11 |
|---|